|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.165 EUR | +1.30% |
|
+2.19% | -20.75% |
| 06-29 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
| 06-22 | Erfo Keeps Buying Back Stock, Repurchases 28,000 Shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 2012-12-31 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 2012-12-31 |
Flavio Corpina
BRD | Director/Board Member | 47 | 2016-12-31 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.30% | +2.19% | -14.34% | +6.88% | 11.16M | ||
| +1.86% | +7.65% | +55.77% | +163.08% | 1,063B | ||
| +3.57% | +7.42% | +69.09% | +61.03% | 611B | ||
| +3.99% | +7.37% | +36.87% | +93.37% | 444B | ||
| +4.17% | -0.96% | +26.12% | +20.22% | 324B | ||
| +4.94% | +4.51% | +39.76% | +28.93% | 285B | ||
| +2.42% | +2.96% | +30.77% | +42.24% | 283B | ||
| +2.47% | +6.56% | -24.26% | -39.60% | 219B | ||
| +3.55% | +6.05% | +26.04% | +66.28% | 195B | ||
| +4.21% | +6.00% | +17.72% | +71.11% | 156B | ||
| Average | +3.14% | +2.63% | +26.35% | +51.35% | 358.07B | |
| Weighted average by Cap. | +2.88% | +4.16% | +41.60% | +82.16% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















